Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601)

By sjmartinez • June 10, 2024

Sedrak MS, Lee MK, Ji J, Satele DV, Freedman RA, Poorvu PD, O'Connor T, Williams GR, Hopkins JO, Muss HB, Cohen HJ, Partridge AH, Carey LA, Chow SL, Subbiah N, Le-Rademacher J, Jatoi A. Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601). J Geriatr Oncol. 2024 Jun 8;15(6):101813. doi: 10.1016/j.jgo.2024.101813. Epub ahead of print. PMID: 38852379.

Tags: breast cancer, Endocrine therapy, Hematology/Oncology, Older adults, Palbociclib, Publications

Related Posts

Final Survival Outcomes With Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated EGFR-Mutated Metastatic NSCLC: RELAY Japanese Subset

Nishio M, Seto T, Reck M, Garon EB, Nishio K, Kasahara K, Nishino K, Satouchi M, Yoh K, Hayashi H, Sakai K, Enatsu S, Frimodt-Møller[...]

Adequacy of Immune Checkpoint Inhibitor-Associated Thyroid Function Monitoring After Therapy

Velez MA, Kang ES, Thompson CA, Lind-Lebuffe J, Shen C, Park SJ, Han A, Gower A, Li D, Rochigneux P, Grogan TR, Elashoff DA, Garon[...]

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Janjigian YY, Al-Batran SE, Wainberg ZA, Muro K, Molena D, Van Cutsem E, Hyung WJ, Wyrwicz L, Oh DY, Omori T, Moehler M, Garrido M,[...]